Name: UMIN ID:
Unique ID issued by UMIN | UMIN000016115 |
---|---|
Receipt number | R000018716 |
Scientific Title | Phase II trial of regorafenib in patients with imatinib resistrant gastrointestinal stromal tumor |
Date of disclosure of the study information | 2015/01/13 |
Last modified on | 2019/01/07 09:25:50 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/01/05 15:39:32 | ||
2 | Update | 2015/01/26 20:03:31 | Recruitment status |
|
3 | Update | 2015/04/13 13:36:18 | Organization Organization Organization Institute Organization1 |
|
4 | Update | 2016/02/05 09:49:41 | Email |
|
5 | Update | 2016/05/13 14:51:58 | Name of primary person or sponsor Organization Institutions |
|
6 | Update | 2017/01/05 18:09:56 | Anticipated trial start date Last follow-up date |
|
7 | Update | 2017/12/05 17:19:08 | Recruitment status Anticipated trial start date |
|
8 | Update | 2018/01/06 17:41:33 | Last follow-up date |
|
9 | Update | 2019/01/07 09:20:20 | Recruitment status Date of closure to data entry |
|
10 | Update | 2019/01/07 09:25:50 | Organization Organization Organization Organization Organization Organization Division name Division name Institute Institute |